Variable

 No. (%) /
Mean (SD)/ Median (range)

Age≥ 65 years

36 (67.9)

Women

23 (43.4)

Comorbidity and risk factors
Arterial hypertension
Diabetes mellitus
History of peripheral vessel diseases
COPD

 

44 (83.0)
11 (20.8)
5 (9.4)
9 (17.0)

Ischaemic etiology
Myocardial infarction

24 (45.3)
21 (39.6)

Clinical signs
Chronic AF
SBP (mmHg)
DBP (mmHg)
Pulmonary congestion
Peripheral edema
NYHA Functional class
II
III/IV

 

26 (49.1)
130 (110-180)
80 (50-100)
34 (64.2)
28 (52.8)

18 (34.0)
20 (37.7)/15 (28.3)

Instrumental data
Radiographic data for pulmonary congestion
Echocardiography
LVEDV (ml)
LVESV (ml)
LVEF <40%
PPmax (mmHg)

 

30 (56.6)

137 (58-456)
88 (36-311)
24 (45.3)
49 (30-90)

Therapy at admission
АСЕ/АRB
β-blockers
Acetysal
Statins

 

29 (54.7)
37 (69.8)
14 (26.4)
15 (28.3)

*Inhibitors of angiotensin converting enzyme/аngiotensin receptor blockers;
maximal pressure in a. pulmonalis

Table 1: Characteristics of chronic heart failure patients.